Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 82 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
根据最新的财务报表(Form-10K),Cryo-Cell International Inc 的总资产为 $64,净损失为 $0
CCEL 的关键财务比率是什么?
Cryo-Cell International Inc 的流动比率是 0.83,净利 margin 为 0,每股销售为 $3.77。
Cryo-Cell International Inc 的收入按细分市场或地理位置如何划分?
Cryo-Cell International Inc 最大收入来源是 Umbilical Cord Blood and Cord Tissue Stem Cell Service,在最近的收益报告中收入为 31,551,550。就地区而言, United States 是 Cryo-Cell International Inc 的主要市场,收入为 31,986,106。